Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.

Fernández-Jaén A, Fernández-Mayoralas DM, Fernández-Perrone AL, Jiménez de la Peña M, Recio Rodríguez M, Calleja-Pérez B, Muñoz Jareño N, Arroyo R, Albert J.

Eur J Paediatr Neurol. 2014 May;18(3):295-300. doi: 10.1016/j.ejpn.2013.12.002.

PMID:
24393840
2.

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJ, Barachino L, Perini P, Fischl B, Battistin L, Gallo P.

J Neurol. 2007 Sep;254(9):1212-20.

PMID:
17361339
3.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
4.

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Pareto D, Sastre-Garriga J, Auger C, Vives-Gilabert Y, Delgado J, Tintoré M, Montalban X, Rovira A.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2270-6. doi: 10.3174/ajnr.A4485.

5.

Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.

Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.

J Neurol Sci. 2009 Jul 15;282(1-2):47-54. doi: 10.1016/j.jns.2008.12.034.

PMID:
19201003
6.

Low degree of cortical pathology is associated with benign course of multiple sclerosis.

Calabrese M, Favaretto A, Poretto V, Romualdi C, Rinaldi F, Mattisi I, Morra A, Perini P, Gallo P.

Mult Scler. 2013 Jun;19(7):904-11. doi: 10.1177/1352458512463767.

PMID:
23069877
7.

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.

Calabrese M, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P.

Neurology. 2010 Jan 26;74(4):321-8. doi: 10.1212/WNL.0b013e3181cbcd03.

PMID:
20101038
8.

Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.

Jonkman LE, Rosenthal DM, Sormani MP, Miles L, Herbert J, Grossman RI, Inglese M.

PLoS One. 2015 Oct 20;10(10):e0129380. doi: 10.1371/journal.pone.0129380.

9.

Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.

Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.

J Neurol Sci. 2009 Jul 15;282(1-2):55-60. doi: 10.1016/j.jns.2009.02.322.

PMID:
19286193
10.

Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.

Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P.

Mult Scler. 2012 Dec;18(12):1760-7. doi: 10.1177/1352458512447704.

PMID:
22570359
11.

No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.

Donohue K, Cox JL, Dwyer MG, Aliotta R, Corwin M, Weinstock-Guttman B, Ann Yeh E, Zivadinov R.

J Neuroimaging. 2014 Jan-Feb;24(1):63-7. doi: 10.1111/j.1552-6569.2012.00775.x.

PMID:
23317029
12.

Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.

Kuchling J, Ramien C, Bozin I, Dörr J, Harms L, Rosche B, Niendorf T, Paul F, Sinnecker T, Wuerfel J.

Mult Scler. 2014 Dec;20(14):1866-71. doi: 10.1177/1352458514531084.

PMID:
24781284
13.

Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.

Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R.

AJNR Am J Neuroradiol. 2014 May;35(5):912-9. doi: 10.3174/ajnr.A3788.

14.

Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.

Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF.

Mult Scler. 2015 Apr;21(4):402-14. doi: 10.1177/1352458514543811.

PMID:
25139946
15.

Cortical lesion load associates with progression of disability in multiple sclerosis.

Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P.

Brain. 2012 Oct;135(Pt 10):2952-61. doi: 10.1093/brain/aws246.

PMID:
23065788
16.

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.

Calabrese M, Reynolds R, Magliozzi R, Castellaro M, Morra A, Scalfari A, Farina G, Romualdi C, Gajofatto A, Pitteri M, Benedetti MD, Monaco S.

PLoS One. 2015 Aug 12;10(8):e0135428. doi: 10.1371/journal.pone.0135428.

17.

Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.

Calabrese M, Grossi P, Favaretto A, Romualdi C, Atzori M, Rinaldi F, Perini P, Saladini M, Gallo P.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):49-54. doi: 10.1136/jnnp-2011-300414.

PMID:
21890577
18.

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.

Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):407-14.

PMID:
17550987
19.

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.

Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.

Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270.

PMID:
18987104
20.

MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing.

Catalaa I, Fulton JC, Zhang X, Udupa JK, Kolson D, Grossman M, Wei L, McGowan JC, Polansky M, Grossman RI.

AJNR Am J Neuroradiol. 1999 Oct;20(9):1613-8.

Supplemental Content

Support Center